ImmunityBio, Inc. IBRX
Nov 12, 2026, 3:44 PM EST
- YTD
- +207.32%
- 1 year
- +195.39%
Discussion (3506)
Sign in to join the discussion
I think Dr. PSS is going to Japan because they want him to come and supply them with Anktiva it's that simple. The word is out and they call him. He isn't going country to country selling Anktiva they call him because they want access and supply.
When POS Cramer speaks his voice makes me want to do bad things to bad people. He is a despicable puppet of the MSM and. Wall Street
Way to much time wasted on what shorts may or may not be doing. Focus on the science and the trials and sales and earnings and the enormous potential for future exponential sales growth and profits. They will drive the share price to triple digits.
I hate Jim Cramer he is a 2 faced liar puppet of MSM and Wall Street ? him
Let's see buy 1500 shares day trade it for .38 gain profit $570 fully taxable and be out when it pops $12
1500x12= $18,000
1500x75= $112,500
Or me
550,000x$75=41 million
Have a nice weekend. Know what you own OWN and why.......
With the amazing news that will happen and MSM covering it hello $50-$100
I want ever stupid idiot retail trader to get caught out or light when IBRX pops $5-$15 in seconds
FDA for papillary is guaranteed.....why? It works equally well for papillary and should have had approval 2 years ago. Corrupt FDA maintained 80% market share in bladder cancer for Keytruda and Merck.
What's the next approved use. To treat Lymphopenia and hello there are no other meds that treat it. After that lung, possibly treating sepsis by reversing Lymphopenia and restoring the immune system. No competition again for treating sepsis in this way. Pancreatic, lymphoma, curing AIDS reversing long covid and treating Lynch syndrome. My bet someday will be involved in all cancer therapy and many chronic infectious diseases too. That's why you invest and don't trade
Nothing magical about 7.50 or any of the other crap getting posted about trends support levels.
The future is all about approval for papillary bladder cancer and ongoing clinical trials.
The future share price is about + news sales growth and turning a profit.
It's not complicated if you are an investor in ImmunityBio.
For you day trading fools : LMAO at the posts
Ok I am not an attorney but I don't think you can claim a loss and join a class action like these unless you actually realized the loss. So bought at 9-12 and sold at a loss.
These class actions are evil and about fixing the shorts issues.
